← Back to Clinical Trials
Recruiting NCT07133555

NCT07133555 Safe Spaces 4 Sexual Health

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT07133555
Status Recruiting
Phase
Sponsor Johns Hopkins University
Condition HIV Counseling and Testing
Study Type INTERVENTIONAL
Enrollment 100 participants
Start Date 2025-08-10
Primary Completion 2026-05-31

Trial Parameters

Condition HIV Counseling and Testing
Sponsor Johns Hopkins University
Study Type INTERVENTIONAL
Phase N/A
Enrollment 100
Sex MALE
Min Age 18 Years
Max Age 49 Years
Start Date 2025-08-10
Completion 2026-05-31
Interventions
Healthcare counseling service

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

Brief Summary

In an earlier study, the study team carried out an HIV/Sexually transmitted infection (STI) testing approach which found men who have sex with men (MSM) at-risk of getting or spreading HIV in online spaces and linked them to testing services on a mobile van. The goal of this present study is to add on to this approach by connecting participants (MSM aged 18-49 residing in the Baltimore area) with a peer health navigator to support them with getting pre-exposure prophylaxis (PrEP) or HIV care services after testing. Researchers will compare using a peer health navigator approach to using a referrals-only approach to get PrEP or HIV care services. Participants will be assigned to either Arm A (group that receives peer health navigator help) or Arm B (group that gets referred) to get PrEP or HIV care.

Eligibility Criteria

Inclusion Criteria: * Male * 18-49 years of age * Ability to read and speak English * Baltimore area resident * Report sex with a male in the past 12 months Exclusion Criteria: * not male-self identified individual

Related Trials

Related Intelligence Guides

In-depth guides covering this condition's trials, eligibility, and what to expect.

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology